Point72 Hong Kong’s Filana Therapeutics FLNA Stock Holding History

Point72 Hong Kong’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,031	Closed	-$43K	–	1393
2022 Q3	$43K	Buy	+1,031	New	+$27.8K	﹤0.01%	1458
2022 Q1	–	Sell	-3,732	Closed	-$163K	–	2269
2021 Q4	$163K	Buy	3,732 +3,627	+3,454%	+$190K	0.01%	1061
2021 Q3	$7K	Buy	+105	New	+$8.76K	﹤0.01%	1817

Other funds holding FLNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCM

Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Point72 Hong Kong's FLNA Position: Q4 2022 in Review

Point72 Hong Kong sold out of Filana Therapeutics (FLNA) in Q4 2022, closing a stake of 1,031 shares — an estimated $43K sold.

Point72 Hong Kong first reported a position in FLNA in Q3 2021 and held it in 3 quarters. The position peaked at $163K in Q4 2021. 153 funds tracked by Wall St. Rank hold FLNA as of Q4 2022.

Point72 Hong Kong reported no remaining Filana Therapeutics position as of Q4 2022 after selling out during the quarter.
Point72 Hong Kong sold 1,031 Filana Therapeutics shares in Q4 2022, an estimated $43K.
Point72 Hong Kong first reported a position in Filana Therapeutics in Q3 2021 and held it in 3 quarters.
Point72 Hong Kong's Filana Therapeutics position peaked at $163K in Q4 2021.
153 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.